Found: 14
Select item for more details and to access through your institution.
Severe parkinsonism under treatment with antipsychotic drugs.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 1, p. 35, doi. 10.1007/s00406-019-01060-7
- By:
- Publication type:
- Article
Mental health in refugees and asylum seekers (MEHIRA): study design and methodology of a prospective multicentre randomized controlled trail investigating the effects of a stepped and collaborative care model.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 1, p. 95, doi. 10.1007/s00406-019-00991-5
- By:
- Publication type:
- Article
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 1, p. 83, doi. 10.1007/s00406-019-01063-4
- By:
- Publication type:
- Article
Therapy resistance/chronicity, their determinants and potential solutions.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Pharmacotherapy of psychiatric inpatients with adjustment disorder: current status and changes between 2000 and 2016.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 1, p. 107, doi. 10.1007/s00406-019-01058-1
- By:
- Publication type:
- Article
Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 1, p. 11, doi. 10.1007/s00406-019-01053-6
- By:
- Publication type:
- Article
Cannabidiol: a hope to treat non-motor symptoms of Parkinson's disease patients.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 1, p. 49, doi. 10.1007/s00406-019-01017-w
- By:
- Publication type:
- Article
A proteomic signature associated to atypical antipsychotic response in schizophrenia patients: a pilot study.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 1, p. 127, doi. 10.1007/s00406-019-01002-3
- By:
- Publication type:
- Article
Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 1, p. 71, doi. 10.1007/s00406-018-0975-2
- By:
- Publication type:
- Article
Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 1, p. 59, doi. 10.1007/s00406-018-0971-6
- By:
- Publication type:
- Article
Inhibition of monoamine oxidase activity by repetitive transcranial magnetic stimulation: implications for inter-train interval and frequency.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 1, p. 119, doi. 10.1007/s00406-018-0969-0
- By:
- Publication type:
- Article
Use of benzodiazepines and z-drugs not compliant with guidelines and associated factors: a population-based study.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 1, p. 3, doi. 10.1007/s00406-018-0966-3
- By:
- Publication type:
- Article
Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993–2015.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2020, v. 270, n. 1, p. 23, doi. 10.1007/s00406-018-0959-2
- By:
- Publication type:
- Article